This video highlights a new study that found that markers of immune response in prostate cancer may be able to predict patients’ response to radiation therapy, likelihood of recurrence, and survival.
Shuang George Zhao, MD, MSE
Advertisement
Articles by Shuang George Zhao, MD, MSE
Advertisement
Latest Updated Articles
ASTRO 2017: Immune Markers in Prostate Cancer Predict RT ResponsePublished: October 4th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
3
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
4
Palazestrant Combo Shows Preliminary Activity in ER+/HER2– Breast Cancer
5
